Commonwealth Equity Services Inc boosted its holdings in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 4.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 36,038 shares of the medical research company’s stock after acquiring an additional 1,575 shares during the quarter. Commonwealth Equity Services Inc’s holdings in Thermo Fisher Scientific were worth $6,818,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Amalgamated Bank boosted its position in Thermo Fisher Scientific by 57.0% during the 2nd quarter. Amalgamated Bank now owns 44,921 shares of the medical research company’s stock worth $7,837,000 after acquiring an additional 16,308 shares during the period. Mutual of America Capital Management LLC boosted its position in Thermo Fisher Scientific by 2.1% during the 2nd quarter. Mutual of America Capital Management LLC now owns 47,728 shares of the medical research company’s stock worth $8,327,000 after acquiring an additional 977 shares during the period. Mitchell Capital Management Co. boosted its position in Thermo Fisher Scientific by 40.3% during the 2nd quarter. Mitchell Capital Management Co. now owns 44,940 shares of the medical research company’s stock worth $7,841,000 after acquiring an additional 12,910 shares during the period. State Board of Administration of Florida Retirement System boosted its position in Thermo Fisher Scientific by 0.9% during the 2nd quarter. State Board of Administration of Florida Retirement System now owns 580,712 shares of the medical research company’s stock worth $101,317,000 after acquiring an additional 5,213 shares during the period. Finally, San Francisco Sentry Investment Group CA acquired a new stake in shares of Thermo Fisher Scientific during the 2nd quarter valued at about $1,451,000. Hedge funds and other institutional investors own 86.16% of the company’s stock.

Shares of Thermo Fisher Scientific Inc (TMO) traded up $1.42 during mid-day trading on Thursday, hitting $183.87. The company had a trading volume of 2,262,900 shares, compared to its average volume of 1,561,349. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.26 and a quick ratio of 0.81. Thermo Fisher Scientific Inc has a 1-year low of $139.88 and a 1-year high of $201.20. The company has a market cap of $73,161.61, a P/E ratio of 20.05, a price-to-earnings-growth ratio of 1.67 and a beta of 1.06.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Wednesday, October 25th. The medical research company reported $2.31 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.24 by $0.07. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. The business had revenue of $5.12 billion for the quarter, compared to the consensus estimate of $5.03 billion. During the same period last year, the business earned $2.03 EPS. The firm’s revenue was up 13.9% compared to the same quarter last year. sell-side analysts predict that Thermo Fisher Scientific Inc will post 9.36 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Investors of record on Friday, December 15th will be paid a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.33%. The ex-dividend date of this dividend is Thursday, December 14th. Thermo Fisher Scientific’s payout ratio is 10.19%.

In related news, CEO Marc N. Casper sold 50,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 15th. The stock was sold at an average price of $188.39, for a total value of $9,419,500.00. Following the transaction, the chief executive officer now directly owns 252,577 shares of the company’s stock, valued at approximately $47,582,981.03. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.49% of the stock is currently owned by company insiders.

Several brokerages have recently issued reports on TMO. Zacks Investment Research lowered Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a report on Monday, September 18th. Barclays reiterated an “overweight” rating and set a $215.00 price target (up from $200.00) on shares of Thermo Fisher Scientific in a report on Monday, September 25th. Argus reiterated a “buy” rating on shares of Thermo Fisher Scientific in a report on Tuesday, August 22nd. They noted that the move was a valuation call. Jefferies Group reiterated a “hold” rating and set a $195.00 price target on shares of Thermo Fisher Scientific in a report on Thursday, September 28th. Finally, Morgan Stanley reiterated an “overweight” rating and set a $220.00 price target on shares of Thermo Fisher Scientific in a report on Wednesday, September 6th. One equities research analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $205.21.

COPYRIGHT VIOLATION NOTICE: “Commonwealth Equity Services Inc Increases Holdings in Thermo Fisher Scientific Inc (TMO)” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another publication, it was illegally copied and reposted in violation of U.S. and international copyright & trademark laws. The legal version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/12/07/commonwealth-equity-services-inc-increases-holdings-in-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Stock Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related stocks with our FREE daily email newsletter.